Results 151 to 160 of about 289,325 (184)

Defining Refractory Migraine and Refractory Chronic Migraine: Proposed Criteria From the Refractory Headache Special Interest Section of the American Headache Society [PDF]

Headache, 2008
Certain migraines are labeled as refractory, but the entity lacks a well‐accepted operational definition. This article summarizes the results of a survey sent to American Headache Society members to evaluate interest in a definition for RM and what were considered necessary criteria.
Richard B. Lipton, Peter Goadsby, B Lee Peterlin   +2 more
exaly   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Current Concepts in Refractory Migraine

Current Treatment Options in Neurology, 2012
The Refractory or Intractable Migraine (RM) patient has long been a challenge to all healthcare providers (HCP). Headache specialists have recognized this sub group of patients who remain refractory to treatment. Despite this recognition, there are no formal criteria that characterize RM.
Elliott, Schulman, Brian E, McGeeney
openaire   +2 more sources

Reaching International Consensus on the Definition of Refractory Migraine Using the Delphi Method [PDF]

Cephalalgia
Aim: Despite its frequency in tertiary headache centers, the International Classification of Headache Disorders, 3rd edition (ICHD-3) does not include refractory migraine.
Lawrence Robbins, Raffaele Ornello, Mario Fernando Prieto Peres   +2 more
exaly   +4 more sources

Open-Label Zonisamide for Refractory Migraine

Clinical Neuropharmacology, 2004
Zonisamide is a novel anticonvulsant drug with multiple mechanisms of action, many of which may confer efficacy in the treatment of migraine headaches. This study investigated the use of open-label zonisamide in treating patients with refractory migraine headaches.Thirty-four migraine patients were initiated on a 100-mg/day zonisamide dosage, which was
Miles E, Drake, Nancy I, Greathouse, Janet B, Renner, Arito D, Armentbright   +3 more
openaire   +2 more sources

Botox Therapy for Refractory Chronic Migraine

Headache: The Journal of Head and Face Pain, 2005
Chronic migraine is unfortunately both common and often resistant to treatment even with prophylactic medications known to be effective in populations with episodic migraine. We undertook an open‐label study to evaluate the safety and utility of botulinum toxin type A injection therapy for patients with chronic migraine who previously had failed to ...
Stafford, Conway, Curtis, Delplanche, Jessica, Crowder, John, Rothrock   +3 more
openaire   +2 more sources

Marital migraine: A refractory daily headache

Psychosomatics, 1984
Abstract Of forty patients with daily chronic common migraine headaches, only four (17%) of 23 married patients, but 12 (71%) of 17 unmarried patients, responded to prophylactic drug treatment. Unmarried migraine patients were more likely to acknowledge emotional stress and to seek psychotherapy.
H J, Featherstone, B D, Beitman
openaire   +2 more sources

Refractory Migraine in a “Just World”

Headache: The Journal of Head and Face Pain, 2014
The “just world hypothesis” is the belief that a poor outcome to treatment always implies patient noncompliance. However, all disease states have a spectrum of severity, with the most severe end representing treatment failures despite compliant patients and excellent care.
openaire   +2 more sources

Migraine Surgery: A Plastic Surgery Solution for Refractory Migraine Headache

Plastic and Reconstructive Surgery, 2011
Migraine headache can be a debilitating condition that confers a substantial burden to the affected individual and to society. Despite significant advancements in the medical management of this challenging disorder, clinical data have revealed a proportion of patients who do not adequately respond to pharmacologic intervention and remain symptomatic ...
Theodore A, Kung, Bahman, Guyuron, Paul S, Cederna   +2 more
openaire   +2 more sources

Zonisamide for Migraine Prophylaxis in Patients Refractory to Topiramate

Clinical Neuropharmacology, 2009
Topiramate is a sulfamate-substituted monosaccharide that has proven efficacy in reducing migraine attacks frequency and severity and has similar mechanisms of action and side effects profile to zonisamide. Although there are some studies suggesting a potential role of this drug in migraine prophylaxis, data are still scarce.
Pedro Emilio, Bermejo, Rodolfo, Dorado
openaire   +2 more sources

Droperidol Treatment of Status Migrainosus and Refractory Migraine

Headache: The Journal of Head and Face Pain, 1997
We conducted a pilot study of intravenous droperidol in 35 patients (32 women and 3 men; mean age 43 years) with status migrainosus (n=25) or refractory migraine (n=10) in an ambulatory infusion center. Headache was graded as severe in 21 patients and moderate in 14. An intravenous line was started and kept open.
S J, Wang, S D, Silberstein, W B, Young
openaire   +2 more sources